Willow Biosciences Announces Changes to Board and Management

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing indust...

March 29, 2023 | Wednesday | News
Healthcare Revolution: Medical Tourism and the American Dream

This year's Healthcare Revolution is about the failings of the American Dream with rising and unsustainable healthcare costs, and how employers can navigat...

March 29, 2023 | Wednesday | News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | Tuesday | News
Labviva raises $20M in Series A to revolutionize life sciences procurement with AI

-Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million ...

March 28, 2023 | Tuesday | News
Imvax Announces First Patient Dosed in Phase 2b Trial of IGV-001 for Glioblastoma

-Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced dosing of the first pati...

March 28, 2023 | Tuesday | News
Teva's Collaboration with Rimidi Expands to Integrate Respiratory Monitoring with US Health System

California’s Desert Oasis Healthcare (DOHC) implements Rimidi’s Respiratory Module for respiratory patient monitoring, based on data collecte...

March 28, 2023 | Tuesday | News
New InnoGenomics Technology Revolutionizes DNA Testing of Sexual Assault Samples

Addressing a long-term shortcoming in DNA evidence for rape and sexual assault cases, New Orleans-based InnoGenomics has developed a nanotech method, Sperm...

March 28, 2023 | Tuesday | News
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and acc...

March 26, 2023 | Sunday | News
Premier Health amends circular and announces shareholder meeting results

Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announce...

March 26, 2023 | Sunday | News
Iovance Biotherapeutics Submits BLA for Lifileucel in Advanced Melanoma

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced it h...

March 26, 2023 | Sunday | News
Commercial Supply Agreement Signed for Naloxone Nasal Spray to Reverse Opioid Overdoses

Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone a...

March 26, 2023 | Sunday | News
DM Clinical Research Seeks Children for Multiple Studies Including COVID-19 and Migraine

"There are many reasons parents elect to enroll children in clinical trials including access to vaccines that are not yet available to the general public, ...

March 26, 2023 | Sunday | News
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

"The FDA's accelerated approval program has provided patients with cancer earlier access to novel treatments that can be practice changing," said Richard P...

March 26, 2023 | Sunday | News
Orion Health bolsters North American operations with tech and leadership.

Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of Jame...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close